mortality/aging
| N |
• after administration of OVA peptide 257-264 has no affect on mortality
|
liver/biliary system
| N |
• no morphological abnormalities or increased apoptosis after administration of OVA peptide 257-264
|
|
• extensive infiltration of Valpha2+ CD8+ lymphocytes after administration of OVA peptide 257-264
|
immune system
|
• extensive infiltration of Valpha2+ CD8+ lymphocytes after administration of OVA peptide 257-264
|


Analysis Tools